7 publications
| Name | Date | Type | Actions |
|---|---|---|---|
H1 2021 results H1 2021 results |
29/07/2021 | Half Year Report | |
2021 first half results 2021 Half year results |
29/07/2021 | Public releases | |
2020 annual results 2020 sales: €427.5m (up 8.0% as reported)
EBIT before depreciation of assets arising from acquisitions: €65.3m (up 33.5%)
Net income - Group share: €19.2m (4.5% of sales)
Cash flow: €92.2m
|
01/04/2021 | Public releases | |
2015 First half Results 2015 Half year results |
30/07/2015 | Half Year Report | |
2014 annual results Sustained growth, Reference products drive growth in 2014. |
24/03/2015 | Annual Report | |
Reference products up +13.2%. net income up +9.3% Lure, March 23, 2015 – At its meeting on March 17, 2015, the Vétoquinol S.A. Board of Directors reviewed the Group results and approved the 2014 financial statements. |
23/03/2015 | Public releases | |
Vetoquinol acquires the rights for Profender® from Elanco Animal Health for Canada February 8th, 2021 (Lure, France) - Vetoquinol announced today the acquisition of the Canadian rights to Profender® product family from Elanco Animal Health. |
08/02/2021 | press release excluding results |